Skip to main content

Advertisement

Table 2 Results in VDRA + −group

From: Effect of vitamin-D analogue on albuminuria in patients with non-dialysed chronic kidney disease stage 4–5: a retrospective single center study

  Before After P
Kidney Function
eGFR (ml/min/1,73 m2) 14.7 ± 4.3 13.0 ± 4.6 <0.001
U-Albumin (g/d) 1.81 ± 1.77 1.56 ± 1.57 <0.05
Mineral-Bone
S-calcium (mmol/l) 1.15 ± 0.08 1.14 ± 0.07 ns
S-phosphate (mmol/l) 1.52 ± 0.35 1.56 ± 0.39 ns
S-PTH (pmol/l) 29.5 ± 14.9 26.0 ± 11.3 ns
Blood Pressure
Systolic (mmHg) 151 ± 20 146 ± 19 <0.05
Diastolic (mmHg) 85 ± 11 83 ± 11 ns
Antihypertensives: (n)
Angiotensin inhibitors* 21 22  
Angiotensin receptor blockers* 24 25  
Calcium antagonists 37 44  
Beta- blockers 28 35  
Others 5 9  
  1. *5 dual in both groups.
  2. Effects of starting treatment with alfacalcidol in 59 patients with secondary hyperparathyroidism and CKD 4–5. Mean ± SD.